PT  - JOURNAL ARTICLE
AU  - McIntosh, James
TI  - American Covid: An Econometric Analysis of Variants
AID  - 10.1101/2022.06.09.22276226
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.06.09.22276226
4099  - http://medrxiv.org/content/early/2022/06/14/2022.06.09.22276226.short
4100  - http://medrxiv.org/content/early/2022/06/14/2022.06.09.22276226.full
AB  - Covid-19 time series data on new cases from the United States for the period January 20, 2020 to February 7, 2022 is analyzed using a distributed lag econometric model applied to the Wild Type, Alpha, and Delta variants to determine the relative efficacy of vaccines and previous infection induced immunity. The results from this study confirm, for the most part, what others have found using large cross section samples: vaccines are effective in dealing with all three variants, more so with Delta. Infection induced immunity is always greater than or equal that delivered by a vaccination and is largest for the Delta variant. However, in the Delta case previous non-Delta infections had no prophylactic value in preventing new Delta infections.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data is publicly available on the Our World in Data website